We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Based on 7 analysts
Target prices reflect the market consensus (mean/high/low), not individual research firms. 28 actions collected · 6 in the last 12 months.
| Date | Firm | Analyst | Action | Rating change | Price target | Report |
|---|---|---|---|---|---|---|
| 2026. 05. 29. | Lake Street | — | Initiate coverage | — → Buy | — | Lake Street: Buy |
| 2026. 05. 21. | Cantor Fitzgerald | — | Initiate coverage | — → Overweight | — | Cantor Fitzgerald: Overweight |
| 2026. 03. 26. | WestPark Capital | — | Initiate coverage | — → Buy | — | WestPark Capital: Buy |
| 2026. 03. 12. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2026. 01. 08. | UBS | — | Initiate coverage | — → Buy | — | UBS: Buy |
| 2025. 09. 13. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 03. 31. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2025. 03. 11. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2024. 11. 07. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2024. 10. 23. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2024. 09. 20. | HC Wainwright & Co. | — | Maintain | Buy → Buy | — | HC Wainwright & Co.: Buy |
| 2024. 08. 19. | HC Wainwright & Co. | — | Initiate coverage | — → Buy | — | HC Wainwright & Co.: Buy |
| 2023. 01. 17. | Piper Sandler | — | Maintain | — → Overweight | — | Piper Sandler: Overweight |
| 2023. 01. 06. | Piper Sandler | — | Upgrade | Neutral → Overweight | — | Piper Sandler: Neutral → Overweight |
| 2023. 01. 06. | Jefferies | — | Upgrade | Hold → Buy | — | Jefferies: Hold → Buy |
| 2022. 11. 03. | SVB Leerink | — | Maintain | — → Market Perform | — | SVB Leerink: Market Perform |
| 2022. 05. 05. | SVB Leerink | — | Downgrade | Outperform → Market Perform | — | SVB Leerink: Outperform → Market Perform |
| 2022. 03. 23. | SVB Leerink | — | Maintain | — → Outperform | — | SVB Leerink: Outperform |
| 2022. 03. 23. | Piper Sandler | — | Downgrade | Overweight → Neutral | — | Piper Sandler: Overweight → Neutral |
| 2022. 03. 12. | Piper Sandler | — | Maintain | — → Overweight | — | Piper Sandler: Overweight |
| 2022. 03. 11. | SVB Leerink | — | Maintain | — → Outperform | — | SVB Leerink: Outperform |
| 2022. 02. 16. | SVB Leerink | — | Maintain | — → Outperform | — | SVB Leerink: Outperform |
| 2022. 01. 07. | JP Morgan | — | Downgrade | Overweight → Neutral | — | JP Morgan: Overweight → Neutral |
| 2022. 01. 07. | SVB Leerink | — | Maintain | — → Outperform | — | SVB Leerink: Outperform |
| 2021. 09. 09. | SVB Leerink | — | Initiate coverage | — → Outperform | — | SVB Leerink: Outperform |
| 2020. 11. 10. | Jefferies | — | Initiate coverage | — → Buy | — | Jefferies: Buy |
| 2020. 11. 10. | JP Morgan | — | Initiate coverage | — → Overweight | — | JP Morgan: Overweight |
| 2020. 11. 10. | Piper Sandler | — | Initiate coverage | — → Overweight | — | Piper Sandler: Overweight |